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Long-Term Exposure of Fine Particulate Matter Causes Hypertension
by Impaired Renal D1 Receptor–Mediated Sodium Excretion via
Upregulation of G-Protein–Coupled Receptor Kinase Type 4
Expression in Sprague-Dawley Rats
Xi Lu, MD;* Zhengmeng Ye, MS;* Shuo Zheng, BS; Hongmei Ren, BS; Jing Zeng, MD; Xinquan Wang, MD, PhD; Pedro A. Jose, MD, PhD;
Ken Chen, MD, PhD; Chunyu Zeng, MD, PhD

Background-—Epidemiological evidence supports an important association between air pollution exposure and hypertension.
However, the mechanisms are not clear.
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Methods and Results-—Our present study found that long-term exposure to ﬁne particulate matter (PM2.5) causes hypertension
and impairs renal sodium excretion, which might be ascribed to lower D1 receptor expression and higher D1 receptor
phosphorylation, accompanied with a higher G-protein–coupled receptor kinase type 4 (GRK4) expression. The in vivo results were
conﬁrmed in in vitro studies (ie, PM2.5 increased basal and decreased D1 receptor mediated inhibitory effect on Na+-K+ ATPase
activity, decreased D1 receptor expression, and increased D1 receptor phosphorylation in renal proximal tubule cells). The
downregulation of D1 receptor expression and function might be attributable to a higher GRK4 expression after the exposure of
renal proximal tubule cells to PM2.5, because downregulation of GRK4 by small-interfering RNA reversed the D1 receptor
expression and function. Because of the role of reactive oxygen species on D1 receptor dysfunction and its relationship with air
pollution exposure, we determined plasma reactive oxygen species and found the levels higher in PM2.5-treated Sprague-Dawley
rats. Inhibition of reactive oxygen species by tempol (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl) reduced blood pressure and
increased sodium excretion in PM2.5-treated Sprague-Dawley rats, accompanied by an increase in the low D1 receptor expression,
and decreased the hyperphosphorylated D1 receptor and GRK4 expression.
Conclusions-—Our present study indicated that long-term exposure of PM2.5 increases blood pressure by decreasing D1 receptor
expression and function; reactive oxygen species, via regulation of GRK4 expression, plays an important role in the pathogenesis of
PM2.5-induced hypertension. ( J Am Heart Assoc. 2018;7:e007185. DOI: 10.1161/JAHA.117.007185.)
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pidemiological evidence supports an important association between air pollution exposure and cardiovascular risks.1 The World Health Organization reported that
>800 000 premature deaths worldwide per year can be
directly attributed to particulate matter air pollution.2 The
ESCAPE (European Study of Cohorts for Air Pollution Effects)

showed that a 5 lg/m3 increase in estimated annual mean
ﬁne particulate matter (PM2.5) was associated with a 13%
increased risk of coronary events.3 Recently, the relationship
between particulate matter and hypertension is getting more
and more attention.4 Dai-Hua Tsai et al found that inhalable
particulate matter short time exposure, a 10 lg/m3 increase
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What Is New?
• Fine particulate matter exposure causes hypertension
because of the dysfunction of the renal dopamine D1
receptor.
• Increased oxidative stress, associated with increased Gprotein–coupled receptor kinase type 4 levels, impairs renal
D1 receptor function and leads to hypertension.

What Are the Clinical Implications?
• Particulate matter air pollution might play an important role
in the pathogenesis of hypertension.
• Restoration of dopamine D1 receptor function by antioxidants may be a therapeutic target for ﬁne particulate
matter–caused hypertension.
Downloaded from http://jaha.ahajournals.org/ by guest on February 2, 2018

in inhalable particulate matter level, is associated with higher
nighttime blood pressure and is preceded by associations with
the reduced ability of the kidney to excrete sodium during the
daytime.5 Numerous investigations have shown that exposure
to PM2.5 elucidated potential biological consequences, such as
modulation of blood pressure, including systemic proinﬂammatory oxidative responses, DNA damage, and autonomic
nervous system imbalance.5–12 However, the underlying
pathophysiological mechanisms of airborne PM2.5-mediated
hypertension are complex and remain to a large extent
unexplored. Studies have shown that hypertension is caused
by prohypertensive factors, which include the increased
activity of the sympathetic nervous system and the decreased
activity of antihypertensive mechanisms, such as sodium
excretion.13 The kidney is endowed with local hormonal
systems that play major roles in the regulation of sodium
transport across the renal proximal tubule (RPT).14 Among
those systems, dopamine is taken as an important one, which
is synthesized in and secreted from RPT cells and decreases
RPT sodium transport,13–17 via the D1 and D3 receptors, by
inhibition of NHE3 at the brush border membrane and Na+-K+ATPase at the basolateral membrane.13 In hypertensive states,
the renal D1 receptor is hyperphosphorylated, which leads to
its dysfunction, and is ascribed to the higher G-protein–
coupled receptor kinase type 4 (GRK4) expression13,18 and
activity in spontaneously hypertensive rats or hypertensive
patients.19–21 This can be linked to increased oxidative
stress.22–25 Many studies have shown that the impaired
intrarenal D1 receptor signaling in hypertension can cause or
be caused by oxidative stress.24–27 Antioxidant supplementation with tempol (4-hydroxy-2,2,6,6-tetramethylpiperidin-1oxyl), a superoxide dismutase (SOD) mimetic, decreases
oxidative stress, restores D1 receptor signaling, and lowers
blood pressure.24,25
DOI: 10.1161/JAHA.117.007185

There are reports that PM2.5 induces hypertension through
impaired sodium excretion and increased reactive oxygen
species (ROS) and oxidative stress28–31; ROS has been
reported to decrease dopamine receptors in animals.24–27
Therefore, we hypothesize that PM2.5, via increased ROS
levels, increases GRK4 expression and consequently impairs
renal D1 receptor function, and leads to hypertension. To test
this hypothesis, we exposed Sprague-Dawley (SD) rats to
PM2.5 in vivo. Concurrently, we also exposed immortalized
RPT cells in vitro, because they behave similarly to freshly
obtained RPT cells, at least with regard to dopamine receptors
and its responses to G-protein stimulation, in this present
study.

Methods
The data, analytic methods, and study materials will be made
available on request to other researchers for purposes of
reproducing the results or replicating the procedure.

PM2.5 Sampling
The sample site was the Daping Hospital, which is 1 km
from the city center. The nearest main road is in the northeast
at a distance of 100 m. Within an 200 m radius of the
monitoring site is almost completely surrounded by residential
areas.
We used a medium volume sampler (model TH-150;
Tianhong Co, Wuhan, China) equipped with a PM2.5 ﬁltration
system to collect PM2.5 samples on ﬁlters (diameter,
150 mm), according to the reported method.32–34 The ﬂow
rate of medium volume sampler was adjusted to 30 m3/h.
After sampling, ﬁlters were shredded into small pieces and
sonicated using an ultrasonator (KQ-250DE; Shumei, Kunshan, Jiangsu, China) for 39 40 minutes in double-distilled
water. The extracted material was frozen, concentrated using
lyophilization, and weighed to determine the extraction
efﬁciency. The farinose solid was stored at 80°C until
further use. The sampling period started on April 8, 2013, and
ended on July 28, 2013. A total of 25 ﬁlters were used to
collect the PM2.5 samples. To make sure the PM2.5 sample
diameter was correct, we performed a scanning electron
microscope analysis of the samples to prove the purity of the
samples. The analysis conﬁrmed that the particulate matter
collected had a diameter of = or <2.5 lm (Figure S1).

Animal Treatment
Male SD rats, 8 to 10 weeks old and initially weighing
1986 g, were given a standard laboratory chow and
ad libitum access to clean drinking water. They were randomly
divided into 3 groups (n=56 for control, n=32 for lower
Journal of the American Heart Association
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Blood Pressure and Urine Collection
Systolic blood pressure, diastolic blood pressure, and mean
arterial blood pressure were measured every week using a
computerized, noninvasive, tail-cuff plethysmography system
in conscious rats (BP-98A; Softron, Tokyo, Japan). The animals
were individually restrained in a clear acrylic restrainer at an
ambient temperature of 37°C to 38°C for 15 minutes. Five
blood pressure values were recorded per rat, and the average
was taken. To ensure the reliability of the measurements, a
training period of 1 week was established before the start of
DOI: 10.1161/JAHA.117.007185

the experiment for the rats to adapt to the method. Blood
pressure measurements were performed between 3 and 5 PM.
SD rats were acclimated in metabolic cages for at least
2 days before urine was collected for 24 hours every week.
After urine collection, sodium and potassium concentrations
in urine samples were measured using a ﬂame photometer
480 (Ciba Corning Diagnostics, Norwood, MA).

Cell Culture and Sample Preparation
Immortalized RPT cells from microdissected Sl segments of
the RPTs from 4- to 8-week-old Wistar-Kyoto rats were
cultured at 37°C in 95% air/5% CO2 atmosphere in DMEM/F12 with transferrin (5 lg/mL), insulin (5 lg/mL), epidermal
growth factor (10 ng/mL), dexamethasone (4 lg/mL), and
5% fetal bovine serum on a 100-mm Petri dish. The ﬁnal
concentration of PM2.5 (1–200 µg/mL) was mixed evenly into
the culture medium, 24 hours prior for the PM2.5 exposure
group, and an equal volume of PBS was mixed into the culture
medium for the control group. Cells were made quiescent by
incubating for 2 hours in the media without fetal bovine
serum before adding the drugs. The cells (80% conﬂuence)
were extracted in ice-cold lysis buffer, sonicated, kept on ice
for 1 hour, and centrifuged at 16 000g for 30 minutes. All
samples were stored at 80°C until use.

Immunoblotting
In the in vivo study, immediately after euthanasia (or after
thawing), the renal cortex (upper pole, left kidney) was
homogenized in buffer (10 mmol/L Tris-HCl, 250 mmol/L
sucrose, 2 mmol/L phenylmethylsulfonyl ﬂuoride, and protease inhibitor cocktail; pH 7.4) and centrifuged at 24 000g
for 25 minutes at 4°C. The upper ﬂuffy layer of the pellet,
which is considered as the membrane fraction, was resuspended in the homogenization buffer.37,38 The samples were
quickly frozen and stored at 80°C until use. For the in vitro
study, the RPT cells were lysed in a lysis buffer, sonicated,
placed on ice for 1 hour, and centrifuged at 16 000g for
30 minutes. The supernatant was stored at 80°C until use.
After boiling the homogenates in sample buffer (35 mmol/
L Tris-HCl, pH 6.8, 4% SDS, 9.3% dithiothreitol, 0.01%
bromophenol blue, and 30% glycerol) at 95°C for 5 minutes,
50 lg of protein was separated by SDS-PAGE (10% polyacrylamide) and then electroblotted onto nitrocellulose membranes (Amersham Life Science, Arlington, TX). The blots
representing the nonspeciﬁc antibodies were blocked overnight with 5% nonfat dry milk in PBS with Tween 20 (0.05%
Tween 20 in 10 mmol/L PBS [isotonic]) at 4°C under
constant shaking, then incubated with polyclonal rabbit antirat GRK4 receptor antibodies (1:400; Santa Cruz Biotechnology, Santa Cruz, CA), overnight at 4°C. The other antibodies
Journal of the American Heart Association
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dosage PM2.5 treatment, and n=56 for higher dosage PM2.5
treatment). The details of each group are shown in Figure S2.
The rats were individually housed in metabolic cages for urine
collection and maintained at a temperature of 252°C, a
relative humidity of 50% to 60%, and a 12-hour dark-light
cycle. An acclimatization period of 2 days was allowed for the
rats before the start of the experiments. The rats were
weighed at the beginning of the experiment and just before
urine collection and euthanasia. This study was approved by
the Third Military Medical University Animal Use and Care
Committee. All experiments conformed to the guidelines of
the ethical use of animals, and all efforts were made to
minimize animal suffering.
PM2.5 was suspended in PBS. To minimize aggregation,
particle suspensions were always sonicated for 15 minutes, 3
times, and vortexed before their dilution and before intratracheal administration. Control animals received PBS treatments. The animals were anesthetized with isoﬂurane and
placed supine with extended necks on an angled board.33,35,36
An oropharynx instillation of the PM2.5 suspension (3 or 30 lg
PM2.5 in 25 lL) or PBS only was instilled (25 lL) via a sterile
syringe. SD rats were treated with the PM2.5 solution every
3 days, for 8 weeks. In the present study, 2 dosages of PM2.5
treatment of either lower or higher dose were used. The lower
dosage given (3 lg PM2.5) represented 35 lg/m3 per
24 hours PM2.5 in the air and was marked as PM2.5-L. The
higher dosage given (30 lg PM2.5) represented 350 lg/m3
per 24 hours PM2.5 in the air and marked as PM2.5-H. To
conﬁrm the success of the exposure model, we performed a
hematoxylin-eosin stain of the lung after the rats were
euthanized (Figure S3). Light microscope detection found the
PM2.5 in the lung tissue.
The blood pressure and 24-hour urine volume and sodium
excretion were measured in conscious rats on the indicated
exposure time points. After 8 weeks of being exposed to
PM2.5-L, PM2.5-H, and PBS, treated rats were randomly
assigned into 2 groups: one group that drank tap water
served as a control, and the other group drank tap water with
1.0 mmol/L tempol that was changed 2 times per day, for
3 weeks (n=12 in each group).
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Determination of D1 Receptor Phosphorylation by
Coimmunoprecipitation
Downloaded from http://jaha.ahajournals.org/ by guest on February 2, 2018

Equal amounts of lysates (1.0 lg protein/mL supernatant
from RPT cells or renal cortex membranes) were incubated
with dopamine D1 receptor (D1R) antibody (2 lg; Millipore) for
2 hours, followed by protein A/G agarose overnight, with
constant rocking at 4°C for 12 hours. The immunoprecipitates were pelleted and washed 3 times with PBS. Then, the
pellets were suspended in sample buffer, boiled for 10 minutes, and subjected to immunoblotting with phosphoserine
antibody (1:400; Immunechem, Burnaby, BC, Canada). To
determine the speciﬁcity of the bands, normal rabbit IgG
(negative control) and D1 receptor antibody (positive control)
were used as the immunoprecipitants. The bound complexes
were detected using the Odyssey Infrared Imaging System (LiCor Biosciences). Band density of the serine-phosphorylated
D1R was normalized by band density of D1R. All the bands
were quantiﬁed by densitometry.

Small-Interfering RNA
Small-interfering RNA (siRNA) against GRK4 mRNA and its
control, scrambled RNA, was synthesized and puriﬁed with
reverse-phased high-performance liquid chromatography as
25-mer phosphorothioate-modiﬁed oligodeoxynucleotides
(GRK4 siRNA sequence, 50 -AUCUAAAGAGGUGCAUUGAAUUCUUdTdT-30 ; scrambled RNA sequence, 50 -TGACGATAAGAACAATAACdTdT-30 ), from nucleotides 412 to 436 and 1752 to
1776, respectively, of the rat GRK4 cDNA. The effects of
50 nmol/L siRNA was compared with scrambled RNA (control). Brieﬂy, cells were grown in 6-well plates until 60%
conﬂuence, and 50 nmol/L siRNA or control RNA was mixed
with 6 lL of Oligofectamine in Optimem medium (Invitrogen
Life Technologies) and incubated for 24 hours, then switched
to growth medium and incubated for another 24 hours. The
cells were collected and processed for reverse transcription–
polymerase chain reaction for GRK4 to determine the
efﬁciency of siRNA-induced GRK4 gene silencing.
DOI: 10.1161/JAHA.117.007185

Cell Counting Kit-8 Assay
As previously described,39 the number of viable cells was
assayed using the Cell Counting Kit-8 (Dojindo Laboratories,
Kumamoto, Japan), per the manufacturer’s protocol. Brieﬂy,
RPT cells were plated into a 96-well plate and incubated with
Cell Counting Kit-8 for 2 hours at 37°C. The optical density
(OD) values were subsequently measured on a spectrophotometer (PerkinElmer) at 490 nm. Three independent experiments were performed.

Real-Time Quantitative Polymerase Chain
Reaction Detecting System
A total of 2 to 3 lg of total RNA extracted from RPT cells or
renal cortex membranes was used to synthesize cDNA, which
served as template for the ampliﬁcation of receptor and
GAPDH (as the reference housekeeping gene). For GAPDH,
the forward primer was 50 -GACATGCCGCCTGGAGAAAC-30
and the reverse primer was 50 -AGCCCAGGATGCCCTTTAGT-30
(GeneBank Accession No. NM_022928.1). For GRK4, the
forward primer was 50 -ACTTCAGCAGACTGGAAGCA-30 and the
reverse primer was 50 -GGTGTCCAGGTTGACTCCTT-30 (GeneBank Accession No. NM_017008.4). For c-Myc, the forward
primer was 50 - ACTTCAGCAGACTGGAAGCA-30 and the reverse
primer was 50 -GGTGTCCAGGTTGACTCCTT-30 (GeneBank
Accession No. AY679730.1). The ampliﬁcation was performed
with the following conditions: denaturation at 95°C for 3
minutes, followed by 35 cycles at 95°C for 10 seconds and
60°C for 30 seconds. At the end of each run, a melting curve
analysis was performed from 65°C to 95°C to monitor primer
dimers or nonspeciﬁc product formation. The reactions were
performed in triplicate. The GRK4 and c-Myc mRNA expression was normalized for GAPDH mRNA.

Na+-K+-ATPase Activity Assay
Na+-K+-ATPase activity was determined as the rate of
inorganic phosphate released in the presence or absence of
ouabain.40,41 Rat RPT cells were treated with vehicle (distilled
water) and D1 receptor agonist,fenoldopam, at the indicated
concentrations and durations of incubation. To prepare
membranes for Na+-K+-ATPase activity assay, RPT cells
cultured in 21-cm2 plastic culture dishes were collected and
centrifuged at 3000g for 10 minutes. The cells were then
placed on ice and lysed in 2 mL of lysis buffer (1 mmol/L
NaHCO3, 2 mmol/L CaCl2, and 5 mmol/L MgCl2). Cellular
lysates were centrifuged at 3000g for 2 minutes to remove
intact cells, debris, and nuclei. The resulting supernatant was
suspended in an equal volume of 1 mol/L sodium iodide, and
the mixture was centrifuged at 48 000g for 25 minutes. The
pellet (membrane fraction) was washed 2 times and suspended in 10 mmol/L Tris containing 1 mmol/L EDTA (pH
Journal of the American Heart Association
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were anti-D1 dopamine receptor antibody (1:400; Millipore,
Billerica, MA), anti–c-Myc (phosphorylated T58+S62) antibody
(1:400; Abcam, Cambridge, UK), and rabbit polyclonal GAPDH
(1:500; Santa Cruz Biotechnology). The membranes were then
further incubated using infrared-labeled secondary antibodies
(donkey anti-rabbit IRDye 800; Li-Cor Biosciences, Lincoln,
NE) to bind to the primary antibody at room temperature for
1 hour. The membranes were washed 3 times in PBS with
Tween 20. The bound complex was detected using the
Odyssey Infrared Imaging System (Li-Cor Biosciences). The
images were analyzed using the Odyssey Application Software
to obtain the integrated intensities.
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Figure 1. Effect of ﬁne particulate matter (PM2.5) exposure on blood pressure and
sodium excretion in Sprague-Dawley (SD) rats. A and B, Effect of PM2.5 exposure on blood
pressure. SD rats received lower (3 lg PM2.5 per time [PM2.5-L]) or higher (30 lg PM2.5
per time [PM2.5-H]) dosage of PM2.5. Systolic blood pressure (SBP) (A) and diastolic blood
pressure (DBP) (B) were recorded by the tail-cuff method (n=12 in each group). C and D,
Effect of PM2.5 exposure on urine volume (C) and urine sodium excretion (D) in SD rats.
Urine was collected in SD rats after exposure with PM2.5 or vehicle for 8 weeks (n=20 in
each group). E and F, Effect of PM2.5 exposure on renal dopamine D1 receptor (D1R)
function in SD rats. Varying dosages of the D1-like receptor agonist, fenoldopam (0.1, 0.5,
and 1.0 lg/kg per minute), were infused into the right suprarenal artery in SD rats after
8-week exposure with PM2.5 or vehicle. The fenoldopam-associated urine volume (E) and
urine sodium excretion (F) were measured (n=12 in each group). G and H, Effect of PM2.5
exposure on renal D1R expression (G) and phosphorylation (H) in SD rats. Renal cortical
membranes were prepared in SD rats exposed to PM2.5 or vehicle for 8 weeks. D1R
phosphorylation was normalized by total D1R expression (n=10 in each group). I and J,
Effect of PM2.5 exposure on renal G-protein–coupled receptor kinase 4 (GRK4) mRNA (I)
and protein (J) expressions in SD rats (n=10 in each group). *P<0.0001 vs control rats,
#
P<0.0001 vs PM2.5-H group.
7.4). Protein concentrations were determined by the Bradford
assay (Bio-Rad Laboratories, Hercules, CA) and adjusted to
1 mg/mL. The membranes were stored at 70°C until use.
To measure Na+-K+-ATPase activity, 100-lL aliquots of
membrane fraction were added to an 800-lL reaction mixture
(75 mmol/L NaCl, 5 mmol/L KCl, 5 mmol/L MgCl2,
6 mmol/L sodium azide, 1 mmol/L Na4EGTA, 37.5 mmol/L
imidazole, 75 mmol/L Tris-HCl, and 30 mmol/L histidine; pH
DOI: 10.1161/JAHA.117.007185

7.4), with or without 1 mmol/L ouabain (ﬁnal volume=1 mL),
and preincubated for 5 minutes in a water bath at 37°C.
Reactions were initiated by adding Tris-ATP (4 mmol/L) and
terminated after 15 minutes of incubation at 37°C by adding
50 lL of 50% trichloroacetate. For determination of ouabaininsensitive ATPase activity, NaCl and KCl were omitted from
the reaction mixtures containing ouabain. To quantify the
amount of phosphate produced, 1 mL of coloring reagent
Journal of the American Heart Association
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Figure 1. Continued.
(10% ammonium molybdate in 10N sulfuric acid and 10N
ferrous sulfate mix buffer) was added to the reaction mixture.
The mixture was then mixed thoroughly and centrifuged at
3000g for 10 minutes. Formation of phosphomolybdate was
determined spectrophotometrically at 740 nm, against a
standard curve prepared from K2HPO4. Na+-K+-ATPase activity
was estimated as the difference between total and ouabaininsensitive ATPase activity and expressed as percentage
change of control.
To eliminate the effect of proteases and phosphatases,
protease inhibitors (1 mmol/L phenylmethylsulfonyl ﬂuoride
and 10 lg/mL each leupeptin and aprotinin) and a phosphatase inhibitor (50 lmol/L sodium orthovanadate) were
added in all solutions used after drug/vehicle incubations.

Fenoldopam-Induced Diuresis and Natriuresis
Twelve rats were selected from each group randomly and
used for fenoldopam infusion study. A total of 36 rats from
control, PM2.5-L, and PM2.5-H groups were anesthetized with
pentobarbital (50 mg/kg IP), placed on a heated board to
maintain body temperature at 37°C, and tracheotomized (PE100). Catheters (PE-50) were placed into the external jugular
and femoral veins and left carotid artery for ﬂuid administration and blood pressure monitoring. Systemic blood pressure
was monitored electronically using Cardiomax II (Columbus
Instruments, Columbus, OH). Laparotomy was performed to
expose the left and right ureters, which were then separately
catheterized for urine collection. The right suprarenal artery
DOI: 10.1161/JAHA.117.007185

(which originates from the right renal artery) was located and
catheterized (PE-10; heat stretched to 180 lm). After a 60minute stabilization period, a normal saline load equivalent to
5% of body weight was infused intravenously for 30 minutes.
After the short-term saline load, a 60-minute stabilization
period was allowed before starting the urine collection.37
Five consecutive 40-minute urine samples were collected:
Vehicle was given during the ﬁrst collection period (control).
In the next 3 periods, the mice received fenoldopam, a D1-like
receptor agonist, at 3 different dose rates of 0.1, 0.5, and1
lg/kg per minute, each dose that has been shown not to
affect blood pressure in previous studies.30,31 During the last
collection period (recovery), only the vehicle, normal saline,
was infused. This was considered as the recovery phase of the
experiment. The change in all infusates (vehicle and reagents)
was commenced 10 minute before each period to account for
the dead space in the delivery catheter. All infusions (vehicle
and reagents) were given at a rate of 40 lL/h. Fluid losses
throughout the experiment were replaced intravenously with
5% albumin at 1% body weight over 30 minutes. The rats were
euthanized with an overdose of pentobarbital (100 mg/kg) at
the end of the experiment right after the last sample was
collected. Urine samples were stored at 80°C until use.

Biochemical Markers of Oxidative Stress
To assess total oxidative stress, plasma samples from rats
were used to measure SOD activity using an SOD Assay Kit
(Dojindo Laboratories), following the manufacturer’s
Journal of the American Heart Association
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Figure 2. Effect of ﬁne particulate matter (PM2.5) exposure in in vitro study in renal proximal
tubule (RPT) cells. A, Effect of PM2.5 exposure on cell viability in RPT cells. Cell viability was
assayed using Cell Counting Kit-8 after exposure to vehicle (distilled water [dH2O]) or PM2.5 for
24 hours. *P<0.0001 vs control (n=9 in each group). B and C, Effect of PM2.5 exposure on Na+K+-ATPase activity in RPT cells. The cells were treated with PM2.5 or vehicle (dH2O) for 24 hours.
Results are expressed as percentage change of control (B). *P<0.0001 vs nonfenoldopam
treatment in each group, #P<0.0001 vs control without fenoldopam and PM2.5 treatment (n=10
in each group). C showed the fenoldopam-induced reduction of Na+-K+-ATPase activity in each
group. *P<0.0001 vs control in C (n=10 in each group). D and E, Effect of PM2.5 exposure on
dopamine D1 receptor (D1R) protein expression (D) and serine phosphorylation (E) in RPT cells.
RPT cells were exposed with 10 or 100 lg/mL concentration of PM2.5 for 24 hours. Results
were expressed as ratio of D1R phosphorylation/total D1R expression. *P<0.05 vs control,
#
P<0.05 vs PM2.5-H group (n=9 in each group). F and G, Effect of PM2.5 exposure on G-protein–
coupled receptor kinase 4 (GRK4) mRNA (F) and protein (G) expressions in RPT cells. RPT cells
were exposed with 10 or 100 lg/mL concentration of PM2.5 for 24 hours. *P<0.01 vs control,
#
P<0.05 vs PM2.5-H group (n=9 in each group).
instructions. Malondialdehyde and glutathione peroxidase in
the plasma were quantiﬁed using a commercially available kit
(Nanjing Jianchen Bioengineering Institute, Nanjing, China).
For in vitro study, the RPT cell culture medium supernatants
were collected to determine SOD, glutathione peroxidase, and
malondialdehyde levels.

Statistical Analysis
The data are expressed as meanSEM. A repeated-measures
ANOVA (dosages of PM2.59time points) was used to determine
the differences of blood pressure, among 3 groups (control,
PM2.5-L, and PM2.5-H) at 0, 2, 4, 6, and 8 weeks. To analyze the
effect of fenoldopam infusion on urine ﬂow and urinary sodium
DOI: 10.1161/JAHA.117.007185

excretion in different dosages of PM2.5-treated groups (control,
PM2.5-L, and PM2.5-H), another repeated-measures (dosages of
PM2.59infusion periods) ANOVA was used. Dosages of PM2.5
were the predictor in these analyses. The Mauchly test of
sphericity was performed using Greenhouse-Geisser adjustment. Moreover, to determine the difference between groups
that have been split on 2 dependent variables (whether
fenoldopam treatment in cells and the dosage of PM2.5 [0, 10,
and 100 lg/mL]) and their interaction, the 2-way ANOVA was
also performed. Besides, other comparisons among groups (or t
test when only 2 groups were compared) was made by 1-way
ANOVA with Holm-Sidak test. Post hoc multiple comparisons
were performed by least signiﬁcant difference method. P<0.05
was considered signiﬁcant.
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Figure 2. Continued.

Results
Effects of PM2.5 Exposure on Blood Pressure and
D1 Receptor–Mediated Sodium Excretion in SD
Rats
Long-term exposure to PM2.5 caused a signiﬁcant increase in
both systolic and diastolic blood pressures, which were
measured by the tail-cuff method, whether by the high dose
(PM2.5-H) or lower dose (PM2.5-L) of PM2.5 (Figure 1A and 1B).
The differences in blood pressure between the control and
PM2.5-treated rats progressively increased with time (Figure 1A and 1B). The high blood pressure might be ascribed to
impaired sodium excretion, because the basal levels of
sodium excretion were lower in PM2.5-treated SD rats.
Moreover, the higher dose of PM2.5 decreased the sodium
excretion to a greater degree compared with the lower dose
(Figure 1C and 1D).
Because of the important role of the dopamine receptor
on sodium excretion, we also determined the effect of
fenoldopam, a D1-like receptor agonist, on sodium excretion.
Consistent with previous reports,41,42 fenoldopam induced
natriuresis (Figure 1E) and diuresis (Figure 1F) in SD rats.
However, after the treatment of SD rats by PM2.5 for
DOI: 10.1161/JAHA.117.007185

8 weeks, the fenoldopam-induced natriuresis and diuresis
were signiﬁcantly decreased (Figure 1E and 1F). Moreover,
the higher dose of PM2.5 worsened the D1 receptor–
mediated sodium excretion to a higher degree compared
with the lower dose of PM2.5 (Figure 1E and 1F). Our
previous studies indicated that hyperphosphorylation of D1
receptor leads to the dysfunction of the renal D1 receptor,
which is ascribed to the higher GRK4 expression and activity
in spontaneously hypertensive rats or hypertensive
patients.17–20 Our additional study found that D1 receptor
expression was lower and GRK4 expression and D1 receptor
phosphorylation were higher in PM2.5-treated SD rats. The
degrees of change were greater with the higher dose of
PM2.5 than the lower dose (Figure 1G through 1J), indicating
GRK4 might be involved in the dysfunction of D1 receptor in
PM2.5-induced hypertension.

Role of GRK4 on PM2.5-Impaired D1 Receptor
Expression and Function in RPT Cells
We used RPT cells to uncover the mechanism of PM2.5induced hypertension. We ﬁrst determined the optimal
concentration of PM2.5 required, and it showed that
Journal of the American Heart Association
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Figure 3. Role of G-protein–coupled receptor kinase 4 (GRK4) on ﬁne particulate matter (PM2.5)–
mediated impairment in renal proximal tubule (RPT) cells. A and B, Effect of GRK4 small-interfering
RNA (siRNA) on GRK4 expression. RPT cells were transfected with siRNA for 24 hours. GRK4 mRNA
expression (A) and protein expression (B) were determined by quantitative polymerase chain reaction
or immunoblotting. *P<0.0001 vs control (n=10 in each group). C and D, Effect of GRK4 siRNA on
Na+-K+-ATPase activity in RPT cells. After transfection with GRK4 siRNA for 24 hours, RPT cells were
treated with PM2.5 (100 lg/mL) or vehicle (distilled water) for another 24 hours. Na+-K+-ATPase
activity was checked with or without the presence of fenoldopam. C, Results are expressed as
percentage change of control. *P<0.0001 vs PM2.5 only (100 lg/mL), #P<0.0001 vs nonfenoldopam
treatment in each group (n=10 in each group). D, Fenoldopam-induced reduction of Na+-K+-ATPase
activity in each group. *P<0001 vs fenoldopam only, #P<0001 vs siRNA treatment (n=10 in each
group). E and F, Effect of GRK4 siRNA on dopamine D1 receptor (D1R) phosphorylation and GRK4
protein expressions in RPT cells exposed to PM2.5 (100 lg/mL). After transfection with GRK4 siRNA
for 24 hours, D1R phosphorylation (E) and GRK4 expression (F) were checked in PM2.5-exposed RPT
cells. *P<0001 vs control, #P<0001 vs PM2.5 only (100 lg/mL) (n=10 in each group).
200 lg/mL PM2.5 decreased RPT cell viability; PM2.5 concentrations from 10 to 100 lg/mL had no effect (Figure 2A).
Therefore, we used 10 and 100 lg/mL as lower and higher
concentrations, respectively, in the in vitro study.
Consistent with previous research ﬁndings,43,44 the selective D1 receptor agonist fenoldopam caused an inhibition of
the Na+-K+-ATPase activity, achieving a maximum of 30% in
the control rats. With PM2.5 exposure, the basal Na+-K+ATPase activity was increased and the fenoldopam-mediated
inhibitory effects on Na+-K+-ATPase activity were reduced
(Figure 2B and 2C). Moreover, we also found that, compared
with control, PM2.5-treated cells had lower D1 receptor
DOI: 10.1161/JAHA.117.007185

expression and higher D1 receptor phosphorylation (Figure 2D and 2E) and GRK4 expression (Figure 2F and 2G).
To further clarify the role of GRK4 on the Na+-K+-ATPase
activity after PM2.5 exposure, we used a speciﬁc GRK4 siRNA
to decrease the expression of GRK4 (Figure 3A and 3B).
Downregulation of GRK4 by the siRNA reduced the increase in
the basal Na+-K+-ATPase activity and reversed the inhibitory
effect of fenoldopam on Na+-K+-ATPase activity in PM2.5treated cells (Figure 3C and 3D). Moreover, the decreased D1
receptor expression (Figure 3E) and increased D1 receptor
phosphorylation (Figure 3F) by PM2.5 were also reversed after
GRK4 siRNA treatment in RPT cells.
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Figure 3. Continued.

Role of ROS in PM2.5-Induced Hypertension and
Impaired Renal Function
ROS has been reported to play a role in the dysfunction of D1
receptor in obese Zucker rats,23,26,27 and there is evidence
showing that PM2.5 increases inﬂammation and ROS production.28,31 Therefore, we wondered whether ROS is involved in
the pathogenesis of PM2.5-induced hypertension. We ﬁrst
measured ROS production in the PM2.5- and vehicle-treated
(control) rats. We found that plasma malondialdehyde levels
were higher, whereas SOD and glutathione peroxidase levels
were lower, in PM2.5-treated rats versus the vehicle-treated
rats (Figure 4A through 4C). The dichloro-dihydro-ﬂuorescein
diacetate staining showed ROS level was signiﬁcantly
increased after PM2.5 treatment in both RPT alone and RPT/
THP-1 cocultured cells, whereas the extent of ROS elevation
was much higher in RPT/THP-1 cocultured cells than those in
RPT cells alone with PM2.5 treatment (Figure S4).
It is known that c-Myc is a transcription factor for GRK4,
and there is evidence that ROS increases c-Myc expression.45–47 We, therefore, tried to determine whether PM2.5
increased GRK4 via the c-Myc pathway. Results showed that
c-Myc expression was higher in PM2.5-treated than control
DOI: 10.1161/JAHA.117.007185

cells (Figure 4D and 4E), indicating that PM2.5 might increase
GRK4 expression via an increased c-Myc expression.
To determine directly the role of ROS in PM2.5-induced
hypertension, tempol, an SOD mimetic, was used to treat
PM2.5 rats, which were exposed to PM2.5 for 8 weeks. After
tempol (1.0 mmol/L in drinking water24,25) treatment for
3 weeks, the increased malondialdehyde and the decreased
SOD/ glutathione peroxidase levels were recovered in PM2.5
rats (Figure 5A through 5C). Furthermore, the sodium excretion was increased, and blood pressure was lowered, in PM2.5
rats (Figure 5D through 5G), and the fenoldopam-induced
natriuresis and diuresis were also recovered in PM2.5-exposed
rats (Figure 5H and 5I), accompanied with a recovered renal
D1 receptor expression and phosphorylation and GRK4
expression (Figure 5J and 5K). It is interesting to ﬁnd that
the renal c-Myc expression is also reduced after treatment
with tempol in PM2.5-exposed rats (Figure 5L and 5M), which
further indicated the role of c-Myc in the PM2.5-induced
hypertension.
Consistent with the in vivo study, PM2.5 increased malondialdehyde and ROS concentrations in the supernatants from
RPT cells, which were normalized by tempol (200 lmol/L)
treatment (Figure 6A and 6B), whereas the high expression of
Journal of the American Heart Association
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Figure 4. Effect of ﬁne particulate matter (PM2.5) exposure on oxidative stress and c-Myc expression in Sprague-Dawley (SD) rats. SD rats
were exposed with lower (3 lg PM2.5 per time [PM2.5-L]) or higher (30 lg PM2.5 per time [PM2.5-H]) dosage of PM2.5 for 8 weeks. Plasma
superoxide dismutase (SOD) (A), glutathione peroxidase (GSH-Px) (B), and malondialdehyde (MDA) (C) levels, and c-Myc mRNA (D) and protein
(E) expressions were determined in those rats. *P<0.005 vs control rats, #P<0.001 vs PM2.5-H group (n=12 in each group).
c-Myc was decreased (Figure 6C and 6D). Moreover, tempol
reversed the fenoldopam-mediated inhibitory effects on Na+K+-ATPase activity in PM2.5-treated RPT cells (Figure 6E and
6F). Meanwhile, the lowered renal D1 receptor expression and
the upregulated renal D1 receptor phosphorylation and GRK4
expression were normalized by tempol in PM2.5-treated RPT
cells (Figure 6G and 6H).

Discussion
Exposure to ambient particulate matter has been associated
with increased hospital admission and mortality for cardiovascular diseases.4,6,7,29 However, the mechanisms are not
completely understood. Hypertension is an established risk
factor for cardiovascular disease and may be implicated in the
association between ambient particulate matter and cardiovascular morbidity and mortality.11 Epidemiological studies
have shown that trafﬁc4,48 or household49–51 PM2.5 exposure
can increase blood pressure in both the short- and long-term.
Many animal experimental studies have validated the view of
the above-mentioned evidence-based-studies.8,31,52–54 In this
DOI: 10.1161/JAHA.117.007185

study, PM2.5 was conﬁrmed to be associated with increased
blood pressure, and the blood pressure was positively
correlated with the exposure dose within a certain range.
Even a lower concentration of PM2.5 exposure can cause an
increased blood pressure.
Although the mechanisms of PM2.5-induced hypertension
are not clear, some mechanisms, including oxidative stress,
inﬂammatory reaction, changes in sympathetic nerve activity,
DNA damage, and apparent genetic changes, have been
reported to be involved in the pathogenesis of hypertension.6,8,10–12 Our present study and others show the role of
impaired sodium excretion in PM2.5-induced hypertension. It
is known that sodium excretion is regulated by numerous
hormones and humoral factors, including dopamine. Renal
dopamine, independent of renal nerves, plays an important
role in maintaining sodium homeostasis and blood pressure
regulation, especially during moderately increased sodium
intake. Under conditions of moderate sodium excess, the
renal dopaminergic system, mainly the D1R, is responsible for
>50% of renal sodium excretion.13 Abnormalities in renal
dopamine and D1R response to an increased sodium load
Journal of the American Heart Association
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excretion in Sprague-Dawley (SD) rats exposed to ﬁne particulate
matter (PM2.5). SD rats exposed to PM2.5 were treated with tempol
for 3 weeks. Plasma superoxide dismutase (SOD) (A), glutathione
peroxidase (GSH-Px) (B), and malondialdehyde (MDA) (C) levels
were checked in those rats (n=12 in each group). The blood
pressure (D and E) and sodium excretion (F and G) were recorded
(n=12 in each group). Moreover, the fenoldopam-mediated urinary
ﬂow rate (H) and urine sodium excretion rate (I), G-protein–coupled
receptor kinase 4 (GRK4) expression (J), and dopamine D1 receptor
(D1R) phosphorylations (K), as well as c-Myc mRNA (L) and protein
expressions (M) were checked (n=10 in each group). DBP indicates
diastolic blood pressure; PM2.5-H, 30 lg PM2.5 per time; and SBP,
systolic blood pressure. *P<0.0001 vs control rats, #P<0.0001 vs
PM2.5-H rats.
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have been implicated in the diminished natriuretic response
and increase in blood pressure in hypertensive patients and
rodents.13–16,23 The impaired D1R function is ascribed to the
hyperphosphorylation, which leads to the uncoupling of D1R
with G protein.13–16 Our previous study found that the
DOI: 10.1161/JAHA.117.007185

hyperphosphorylated D1R is caused by a constitutively
increased GRK4 activity and expression in hypertension.13,18–21 Consistent with hypertension, our present study
found that D1R-mediated diuresis and natriuresis are impaired
in PM2.5-exposed rats, accompanied with D1R hyperphosphorylation. The increased phosphorylation of D1R is ascribed to
GRK4, because in both in vivo and in vitro studies, GRK4
expression is increased because of PM2.5 exposure; after
downregulation of GRK4 with siRNA, the impaired inhibitory
effect of D1R on Na+-K+-ATPase activity was reversed in RPT
cells exposed to PM2.5. Thus, the current studies support the
notion that GRK4 is involved in the impaired function of renal
D1R in PM2.5-exposed hypertension.
Many studies have indicated that both hypertensive
patients and animals have decreased antioxidant capacity
and produce excessive amounts of ROS.27,55–57 Antioxidant
treatment could mitigate the production of ROS and further
increase antioxidant capacity, such as SOD and glutathione in
plasma and tissue, consequently decreasing the blood
pressure in hypertensive animal models. PM2.5 is known to
increase serum tumor necrosis factor-a level and stimulate
macrophages to generate ROS and enhance oxidative
stress.28–31,33,58–60 Multiple studies have shown that an
impaired intrarenal D1R signaling in hypertension can cause or
be caused by oxidative stress.24–27,61 Our present study found
that tempol treatment would reduce ROS, lower blood
pressure, and reverse the impaired D1R-mediated natriuresis
and diuresis in PM2.5-exposed rats.
As stated previously and in other reports, ROS is related to
the regulation of GRK4 on D1R expression and function and
tempol has been shown to reduce GRK4 level, restore D1R
expression and function, and normalize blood pressure by
decreasing oxidative stress.22,24,25 However, the molecular
mechanisms involved are not well understood. c-Myc, a
human homolog of the avian myelocytomatosis viral oncogene v-Myc, is involved in cancer progression, which has been
implicated in hypertrophy and ﬁbrosis of the heart,
atherosclerosis, and hypertension.45–47 c-Myc was shown to
Journal of the American Heart Association

12

ORIGINAL RESEARCH

Figure 5. Effect of tempol on blood pressure and sodium

PM2.5 Causes Hypertension by Renal D1 Receptor

Lu et al
ORIGINAL RESEARCH

Downloaded from http://jaha.ahajournals.org/ by guest on February 2, 2018

Figure 6. Effect of tempol on Na+-K+-ATPase activity and G-protein–coupled receptor kinase
4 (GRK4) expression in renal proximal tubule (RPT) cells exposed to ﬁne particulate matter
(PM2.5). RPT cells exposed to vehicle (control) or PM2.5 were treated with tempol (200 lmol/L)
for 24 hours. Superoxide dismutase (SOD) (A) and malondialdehyde (MDA) levels (B) were
quantiﬁed in the cell culture medium supernatant. *P<0.0001 vs control, #P<0.0001 vs PM2.5
only (100 lg/mL) (n=12 in each group). c-Myc mRNA (C) and protein (D) expressions were
checked in those cells. *P<0.0001 vs control, #P<0.0001 vs PM2.5 only (100 lg/mL) (n=10 in
each group). Moreover, the Na+-K+-ATPase activity (E and F) and GRK4 expression (G) and
dopamine D1 receptor (D1R) phosphorylations (H) were tested in those cells. *P<0.05 vs
control, #P<0.001 vs PM2.5 treated (100 lg/mL) (n=10 in each group).
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bind to the promoter region of GRK4 in Burkitt lymphoma
cells. Gildea et al found c-Myc may be involved in the increase
in blood pressure in hypertension that is mediated by
increased activity of the renin-angiotensin system and
decreased activity of the renal dopaminergic system.45 Many
other studies also report that ROS increased c-Myc expression.46,47 Our present study found that ROS associated with
increased c-Myc levels and increased GRK4 expression in
PM2.5-exposed rats and cells.
In the present study, the particulate sampling method is
universally accepted,32–34 and we performed a scanning
electron microscope analysis of the samples to determine the
reliability of the samples. To ensure the success of the
exposure model, we also performed a hematoxylin-eosin stain
of the lung after the rats were euthanized, and a light
microscope detection conﬁrmed the presence of PM2.5 in the
lung tissue. According to the World Health Organization’s Air
Quality Guideline, an annual mean PM2.5 concentration of
35 lg/m3 was selected as the level 1 interim target, which
corresponds to the highest mean concentrations reported in
studies of long-term health effects. This level has been shown
to be associated with signiﬁcant mortality in the developed
world.62 For this reason, in this study, the rats received 2
dosages of PM2.5. A lower dosage represented 35 lg/m3 per
24 hours PM2.5, whereas the higher dosage represented
350 lg/m3 per 24 hours PM2.5 in the air.
In summary, our study shows direct evidence supporting
the hypothesis that PM2.5 causes hypertension and, for ﬁrst
time, links the dysfunction of the renal D1R to the hypertension attributable to PM2.5 exposure. Increased oxidative
stress, associated with increased GRK4 levels, impairs renal
D1R function and leads to hypertension. Restoration of D1R
function by antioxidants may be a therapeutic target for
PM2.5-caused hypertension.
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SUPPLEMENTAL MATERIAL

Figure S1. Scanning electron microscopy analysis of PM2.5 samples.
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The scanning electron microscopy analysis of PM2.5 samples showed that the
collected samples were less than 2.5 m in diameter.

Figure S2. The flowchart of animal studies.
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A total 144 SD rats were randomly divided into control, lower dosage PM2.5
treatment, and higher dosage PM2.5 treatment group. And subgroups were further
divided into vehicle (or PM2.5), +fenoldopam, +tempol, and fenoldopam+tempol.

Figure S3. Lung histology from control and exposed rats.
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Representative light microscopy sections of lung tissue from control and PM2.5treated rats, showing particulate matter deposition and without obvious alveolar
inflammatory response.

Figure S4. The ROS generation in RPT cells after PM2.5 exposure.
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RPT cell and THP-1 cell, a clonal monocyte cell line, were co-cultured in a co-culture
system with PM2.5 treatment. After PM2.5 exposure (100μg/ml) for 24 hours,
removal of THP-1 cells, and then ROS in RPT cells was checked by DCFH-DA (2,7dichloro-dihydro-fluorescein diacetate, a ROS fluorescent probe) staining. The ROS
levels were quantified as fluorescent intensity of DCFH-DA. (*P<0.0001 vs. control,
#P<0.0001 vs. THP-1/RPT co-culture cells, n=4 in each group).
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